Dergiler / Medicine Science / 2019 / Cilt: 8 - Sayı: 2

Management of obsessive compulsive disorder induced by the use of clozapine

Sayfa
449–450
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This manuscript presents a case with resistant schizophrenia who developed obsessive compulsive disorder secondary to clozapine treatment and was successfully treated with clomipramine and aims to discuss the case accompanied by the literature.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The second generation antipsychotic of clozapine has superior efficacy compared to other antipsychotics especially for treatment-resistant schizophrenia.
📊
Temel Bulgular & Veri:In up to 20% of patients receiving clozapine treatment, the side effect of obsessive compulsive symptoms or obsessive compulsive disorder occurs.
💡
Sonuç & Katkı:This manuscript presents a case with resistant schizophrenia who developed obsessive compulsive disorder secondary to clozapine treatment and was successfully treated with clomipramine and aims to discuss the case accompanied by the literature.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

The second generation antipsychotic of clozapine has superior efficacy compared to other antipsychotics especially for treatment-resistant schizophrenia. In up to 20% of patients receiving clozapine treatment, the side effect of obsessive compulsive symptoms or obsessive compulsive disorder occurs. These obsessive compulsive side effects sometimes cause cessation of the use of clozapine and sometimes causes difficulties in treating the psychotic symptoms due to dose reductions. This manuscript presents a case with resistant schizophrenia who developed obsessive compulsive disorder secondary to clozapine treatment and was successfully treated with clomipramine and aims to discuss the case accompanied by the literature.

🔖

Bu Makaleye Atıf Yap

DÖNMEZ, Y. E., ÖZCAN, Ö. Ö., SARİOGLU, F. K., GÜNGÖREN, S. (2019). Management of obsessive compulsive disorder induced by the use of clozapine. Medicine Science, Cilt: 8 - Sayı: 2, 449–450. https://ajindex.com/articles/276967

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Kane J, Singer MD, Meltzer MD. Clozapine for the treatment-resistant. Arch Gen Psychiatry. 1988;45:789-96.
  2. Bleakley S, Brown D, Taylor D. Does clozapine cause or worsen obsessive compulsive symptoms? An analysis and literature review. Ther Adv Psychopharmacol. 2011;1:181-8.
  3. Schirmbeck F, Zink M. Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review. Curr Neuropharmacol. 2012;10:88-95.
  4. Fonseka TM, Richter MA, Müller DJ. Second generation antipsychoticinduced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature. Curr Psychiatry Rep. 2014;16:510. Swets M, Dekker J, van Emmerik-van Oortmerssen K, et al. The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalence rates. Schizophr Res. 2014;152:458-68.
  5. Sterk B, Lankreijer K, Linszen DH, et al. Obsessive–compulsive symptoms in first episode psychosis and in subjects at ultra high risk for developing psychosis; onset and relationship to psychotic symptoms. Aust N Z J Psychiatry. 2011;45:400-6.
  6. Lin SK, Su SF, Pan CH. Higher plasma drug concentration in clozapinetreated schizophrenic patients with side effects of obsessive/compulsive symptoms. Ther Drug Monit. 2006;28:303-7.
  7. Ertugrul A, Yagcioglu AEA, Eni N, et al. Obsessive-compulsive symptoms in clozapine-treated schizophrenic patients. Psychiatry Clin Neurosci. 2005;59:219-22.
  8. Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci. 2012;16:43-51.
  9. Menzies L, Chamberlain SR, Laird AR, et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008;32:525-49.
  10. Cai J, Zhang W, Yi Z, et al. Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine induced obsessive compulsive symptoms. Psychopharmacology. 2013;230:49-55.
  11. Zink M, Englisch S, Knopf U, Kuwilsky A, Dressing H. Augmentation of clozapine with valproic acid for clozapine-induced obsessive-compulsive symptoms. Pharmacopsychiatry. 2007;40:202–3.
  12. Canan F, Aydinoglu U, Sinani G. Valproic acid augmentation in clozapineassociated hand-washing compulsion. Psychiatry Clin Neurosci. 2012;66:4634. Biondi M, Fedele L, Arcangeli T, et al. Development of obsessive-compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine. Psychother Psychosom. 1999;68:111-2.
  13. Leung JG, Palmer